• 23118 Citations
  • 82 h-Index
1984 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Paolo Calabresi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 35 Similar Profiles
Corpus Striatum Medicine & Life Sciences
Parkinson Disease Medicine & Life Sciences
Neurons Medicine & Life Sciences
Neuronal Plasticity Medicine & Life Sciences
Long-Term Potentiation Medicine & Life Sciences
Dopamine Medicine & Life Sciences
Interneurons Medicine & Life Sciences
Migraine Disorders Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1984 2019

Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration

Durante, V., de Iure, A., Loffredo, V., Vaikath, N., De Risi, M., Paciotti, S., Quiroga-Varela, A., Chiasserini, D., Mellone, M., Mazzocchetti, P., Calabrese, V., Campanelli, F., Mechelli, A., Di Filippo, M., Ghiglieri, V., Picconi, B., El-Agnaf, O. M., De Leonibus, E., Gardoni, F., Tozzi, A. & 1 others, Calabresi, P., May 1 2019, In : Brain : a journal of neurology. 142, 5, p. 1365-1385 21 p.

Research output: Contribution to journalArticle

Synucleins
Corpus Striatum
alpha-Synuclein
Parkinson Disease
Long-Term Potentiation

Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease

Krashia, P., Cordella, A., Nobili, A., La Barbera, L., Federici, M., Leuti, A., Campanelli, F., Natale, G., Marino, G., Calabrese, V., Vedele, F., Ghiglieri, V., Picconi, B., Di Lazzaro, G., Schirinzi, T., Sancesario, G., Casadei, N., Riess, O., Bernardini, S., Pisani, A. & 6 others, Calabresi, P., Viscomi, M. T., Serhan, C. N., Chiurchiù, V., D’Amelio, M. & Mercuri, N. B., Dec 1 2019, In : Nature Communications. 10, 1, 3945.

Research output: Contribution to journalArticle

Open Access
Parkinson disease
pathology
Pathology
dopamine
rats

Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis

Gaetani, L., Eusebi, P., Mancini, A., Gentili, L., Borrelli, A., Parnetti, L., Calabresi, P., Sarchielli, P., Blennow, K., Zetterberg, H. & Di Filippo, M., Oct 1 2019, In : Multiple Sclerosis and Related Disorders. 35, p. 228-232 5 p.

Research output: Contribution to journalArticle

Intermediate Filaments
Multiple Sclerosis
Cerebrospinal Fluid
Light
Enzyme-Linked Immunosorbent Assay

Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis

Gaetani, L., Salvadori, N., Lisetti, V., Eusebi, P., Mancini, A., Gentili, L., Borrelli, A., Portaccio, E., Sarchielli, P., Blennow, K., Zetterberg, H., Parnetti, L., Calabresi, P. & Di Filippo, M., Sep 1 2019, In : Journal of Neurology. 266, 9, p. 2157-2163 7 p.

Research output: Contribution to journalArticle

Intermediate Filaments
Multiple Sclerosis
Cerebrospinal Fluid
Light
Neuropsychological Tests
Neuronal Plasticity
Huntington Disease
Transgenic Mice
Long-Term Synaptic Depression
Corpus Striatum